Coco Kou
Finanzdirektor/CFO bei QHY GROUP
Aktive Positionen von Coco Kou
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| QHY GROUP | Finanzdirektor/CFO | - | - |
| Comptroller/Controller/Auditor | - | - | |
| FOUR LEAF ACQUISITION CORPORATION | Finanzdirektor/CFO | 01.01.2022 | - |
Karriereverlauf von Coco Kou
Ehemalige bekannte Positionen von Coco Kou
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| XYNOMIC PHARMACEUTICALS HOLDINGS, INC. | Finanzdirektor/CFO | 01.01.2019 | 01.01.2021 |
Salion Food Condiment Co., Ltd.
 Salion Food Condiment Co., Ltd. Food: Major DiversifiedConsumer Non-Durables Salion Food Condiment Co., Ltd. engages in the manufacture of compound condiment products in Northern China. It operates through the following geographical segments: Mainland China, Singapore, Korea, Russia, Europe, and Others. The company was founded on August 23, 2016 and is headquartered in Beijing, China. | Finanzdirektor/CFO | 01.01.2017 | 01.01.2018 |
Ausbildung von Coco Kou
| Peking University | Graduate Degree |
| University of Hong Kong | Masters Business Admin |
| London Business School | Masters Business Admin |
| Columbia Business School | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 4 |
| China | 3 |
| Hong Kong | 2 |
Operativ
| Director of Finance/CFO | 4 |
| Masters Business Admin | 3 |
| Comptroller/Controller/Auditor | 1 |
Sektoral
| Consumer Services | 5 |
| Industrial Services | 2 |
| Consumer Non-Durables | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| QHY GROUP | Industrial Services |
| FOUR LEAF ACQUISITION CORPORATION | Finance |
| Private Unternehmen | 2 |
|---|---|
Salion Food Condiment Co., Ltd.
Salion Food Condiment Co., Ltd. Food: Major DiversifiedConsumer Non-Durables Salion Food Condiment Co., Ltd. engages in the manufacture of compound condiment products in Northern China. It operates through the following geographical segments: Mainland China, Singapore, Korea, Russia, Europe, and Others. The company was founded on August 23, 2016 and is headquartered in Beijing, China. | Consumer Non-Durables |
Xynomic Pharmaceuticals Holdings, Inc.
 Xynomic Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Xynomic Pharmaceuticals Holdings, Inc. is a clinical stage best-in-class oncology therapeutics biopharmaceutical company. It engages in licensing, developing and commercializing oncology drug candidates in China, US, and rest of the world. Its current pipeline mainly consists of 3 drug candidates; Xynomic owns global exclusive development, manufacturing and commercialization rights to each of these. Its lead drug candidate abexinostat is in global potentially pivotal clinical trials against renal cell carcinoma and non-Hodgkin's lymphoma. The company was founded by Yinglin Mark Xu on October 7, 2016 and is headquartered in Shanghai, China. | Health Technology |
